Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue SUPPL. 1, 2012, Pages 8-14

  Tesfaye, Solomon ^a   Selvarajah, Dinesh ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetic neuropathy; Diabetic peripheral neuropathy; MRI; Painful diabetic neuropathy; Pathogenesis of diabetic neuropathy

Indexed keywords

DULOXETINE; HEMOGLOBIN A1C; N ACETYLASPARTIC ACID; OXYCODONE; PREGABALIN; TRAMADOL;

CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; COMORBIDITY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN VIVO STUDY; MORTALITY; NEUROIMAGING; NEUROPATHIC PAIN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; RISK FACTOR; SCINTIGRAPHY; SPINAL CORD;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HUMANS;

EID: 84856201567     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2239     Document Type: Review

References (44)

1. Tesfaye S. Recent advances in the management of diabetic symmetrical polyneuropathy. J Diabetes Invest 2010; 2: 33-42.
2. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003; 26(6): 1790-1795.
3. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diabetes Care 2010; 33(10): 2285-2293.
4. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518-1522.
5. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003; 19(suppl 1): S2-S8.
6. Gore M, Brandenburg N, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptoms manage 2005; 30: 374-385.
7. Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004; 351: 48-55.
8. Tesfaye S, Stephens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39(11): 1377-1384.
9. Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. New Engl J Med 2005; 352: 341-350.
10. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008; 31(3): 464-469.
11. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009; 58(10): 2376-85.
12. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009; 58(7): 1634-40.
13. Forsblom CM, Sane T, Groop PH, et al. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 1998; 41(11): 1253-1262.
14. Coppini DV, Bowtell PA, Weng C, Young PJ, Sonksen PH. Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. J Clin Epidemiol. 2000; 53(5): 519-523.
15. Cameron NA, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44(11): 1973-1988.
16. Malik RA, Tesfaye S, Thompson SD, et al. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 1993; 36(5): 454-459.
17. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, Ward JD. Sural nerve oxygen tension in diabetes. Br Med J (J Clin Res Ed) 1986; 293(6554): 1053-1054.
18. Tesfaye S, Harris N, Jakubowski JJ, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluoroscein angiography. Diabetologia 1993; 36(12): 1266-1274.
19. Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011; 27 629-638.
20. Oyibo S, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002; 19: 870-873.
21. Eaton SE, Harris ND, Ibrahim S, et al. Differnces insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003; 46: 934-939.
22. Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007; 30: 655-659.
23. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883-887.
24. Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular n perfusion abnormalities of the thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care 2011; 34(3): 718-720.
25. Gandhi R, Marques JLB, Selvarajah D, et al. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care 2010; 33: 1585-1590.
26. Manschot SM, Brands AM, van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006; 55(4): 1106-1113.
27. Selvarajah D, Wilkinson ID, Davies J, Gandhi R, Tesfaye S. Central nervous system involvement in diabetic neuropathy. Curr Diab Rep 2011; 11(4): 310-322.
28. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996; 348(9043): 1698-1701.
29. Eaton SE, Harris ND, Rajbhandari SM, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 2001; 358(9275): 35-36.
30. Selvarajah D, Wilkinson ID, Emery CJ, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006; 29: 2664-2669.
31. Wilson P, Kitchener PD, et al. Cutaneous receptive field organization in the ventral posterior nucleus of the thalamus in the common marmoset. J Neurophysiol 1999; 82: 1865-1875.
32. McCormick DA, Bal T. Sensory gating mechanisms of the thalamus. Curr Opin Neurobiol 1994; 4: 550-556.
33. Selvarajah D, Wilkinson ID, Emery CJ, et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 2008; 51: 2088-2092.
34. Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res 2009; 1268(1): 154-161.
35. Fischer TZ, Waxman SG. Neuropathic pain in diabetes-evidence for a central mechanism. Nat Rev Neurol. 2010; 6(8): 462-466.
36. Tracey I. Can neuroimaging studies identify pain endophenotypes in humans? Nat Rev Neurol. 2011; 7(3): 173-181.
37. Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen JI, Carrier B. Pain perception: is there a role for primary somatosensory cortex? Proc Natl Acad Sci U S A 1999; 96(14): 7705-7709.
38. Melzack R. From the gate to the neuromatrix. Pain 1999; Suppl 6: S121-S126.
39. Tracey I, Mantyh P. The cerebral signature for pain perception and its modulation. Neuron 2007; 55(3): 377-391.
40. Wilkinson ID, Gandhi RA, Hunter MD, et al. Functional MRI and response to pain in diabetic neuropathy. Diabet Med 2007; 24(suppl 1): P187.
41. Schweinhardt P, Glynn C, Brooks J, et al. An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients. NeuroImage 2006; 32: 256-265.
42. Selvarajah D, Davies J, Sankar A, et al. Diabetologia 2011; Suppl 1: S81.
43. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with alpha-lipoic acid: a meta-analysis. Diabetic Med 2004; 21: 114-121.